Mechanism of Resveratrol-mediated Suppression of Tissue Factor Gene Expression

Usha R. Pendurthi; Feng Meng; N. Mackman; L. Vijaya Mohan Rao

doi:10.1055/s-0037-1612959

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2002; 87(01): 155-162
DOI: 10.1055/s-0037-1612959

Review Article

Schattauer GmbH

Mechanism of Resveratrol-mediated Suppression of Tissue Factor Gene Expression

Usha R. Pendurthi

¹ Biomedical Research, The University of Texas Health Center at Tyler, Tyler, TX

,

Feng Meng

¹ Biomedical Research, The University of Texas Health Center at Tyler, Tyler, TX

,

N. Mackman

² Department of Immunology, The Scripps Research Institute, La Jolla, CA, USA

,

L. Vijaya Mohan Rao

¹ Biomedical Research, The University of Texas Health Center at Tyler, Tyler, TX

› Author Affiliations

Abstract

Summary

Tissue factor (TF) is a cell surface receptor for factor VII(a), and the binding of factor VII(a) to TF initiates the coagulation cascade. Inappropriate in vivo expression of TF in vascular cells has been shown to be responsible for thrombotic disorders associated with a variety of pathological conditions, including gram-negative sepsis, cancer and atherosclerosis. A number of epidemiological studies suggest that moderate consumption of red wine provides protective effects against coronary heart disease mortality. Recently, we have shown that resveratrol, a polyphenolic compound found in wine, inhibited the induction of TF expression in endothelial cells and mononuclear cells (Pendurthi UR, Williams JT, Rao LVM. Arterioscler Thromb Vasc Biol 1999; 19: 419-426). In the present study, we examined the mechanism by which resveratrol inhibits the expression of TF in monocytes by using a monocytic cell line, THP-1, as a model cell. Northern blot analysis, gel mobility shift assays and transfection studies with various TF promoter constructs, as well as other transcription regulatory constructs, were used to elucidate the inhibitory mechanism of resveratrol. The data show that resveratrol inhibited lipopolysaccharide (LPS)-induced expression of TF in human monocytes and monocytic cell line, THP-1 in a dose dependent manner. Resveratrol did not significantly alter the binding of various transcription factors involved in TF gene expression to DNA. However, resveratrol suppressed the transcription of cloned human TF promoter. Further experiments revealed that resveratrol reduced κB- but not AP-1-driven transcriptional activity. Additional experiments showed that resveratrol suppressed the phosphorylation of p65 and its transactivation. In summary, our results indicate that resveratrol does not inhibit the activation or translocation of NF-κB/Rel proteins but inhibits NF-κB/Rel-dependent transcription by impairing the transactivation potential of p65.

Keywords

Tissue factor - monocytes - gene expression - resveratrol - cardiovascular diseases

Full Text

References

References
1 Suh I, Shaten BJ, Cutler JA, Kuller LH. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The multiple risk factor intervention trial research group. Ann Intern Med 1992; 116: 881-7.
2 Renaud SC, Beswick AD, Fehily AM, Sharp DS, Elwood PC. Alcohol and platelet aggregation: the Caerphilly Prospective Heart Disease Study. Am J Clin Nutr 1992; 55: 1012-7.
3 Renaud S, De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1993; 339: 1523-6.
4 Soleas GJ, Diamandis EP, Goldberg DM. Wine as biological fluid: History, production, and role in disease prevention. J Clin Lab Anal 1997; 11: 287-313.
5 Seimann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 1992; 43: 49-52.
6 Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341: 1103-4.
7 Bertelli AAE, Giovannini L, Giannessi D, Migliori M, Bernini W, Fregoni M, Berteill A. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tiss Reac 1995; 17: 1-3.
8 Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis implications for protection against coronary heart disease. Clin Chim Acta 1995; 235: 207-19.
9 Hsieh T-Z, Juan G, Darzynkiewicz Z, Wu JM. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21, and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res 1999; 59: 2596-601.
10 Chen CK, Pace-Asciak CR. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol 1996; 27: 363-6.
11 Taubman MB, Fallon JT, Schecter AD, Giesen P, Mendlowitz M, Fyfe BS, Marmur JD, Nemerson Y. Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost 1997; 78: 200-4.
12 Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-43.
13 Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB. Identification of active tissue factor in human coronary atheroma. Circulation 1996; 94: 1226-32.
14 Ardissino D, Merlini PA, Arlens R, Coppola R, Bramucci E, Lucreziotti S. et al. Tissue factor in human coronary atherosclerotic plaques. Clinica Chimica Acta 2000; 291: 235-40.
15 McNamara CA, Sarenbock IJ, Gimple LW, Fenton II JW, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 1993; 91: 94-8.
16 Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA 1992; 89: 2317-20.
17 Ruf W, Mueller BM. Tissue factor signaling. Thromb Haemost 1999; 82: 175-82.
18 Prydz HS, Camerer E, Rottingen J-A, Wiiger MT, Gjernes E. Cellular consequences of the initiation of blood coagulation. Thromb Haemost 1999; 82: 183-92.
19 Rao LVM, Pendurthi U. Factor VIIa-induced gene expression: Potential implications in pathophysiology. Trends Cardiovasc Med 2001; 11: 14-21.
20 Pendurthi UR, Williams JT, Rao LVM. Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells. A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. Arterioscler Thromb Vasc Biol 1999; 19: 419-26.
21 Bajaj SP, Rapaport SI, Prodanos C. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem 1981; 11: 397-412.
22 Rao LVM, Robinson T, Hoang AD. Factor VIIa/tissue factor-catalyzed activation of factors IX and X on a cell surface and in suspension: A kinetic study. Thromb Haemost 1992; 67: 654-9.
23 Engstad CS, Gutteberg TJ, Osterud B. Modulation of blood cell activation by four commonly used anticoagulants. Thromb Haemost 1997; 77: 690-6.
24 Pendurthi UR, Williams JT, Rao LVM. Acidic and basic fibroblast growth factors suppress transcriptional activation of tissue factor and other inflammatory genes in endothelial cells. Arterioscler Thromb Vasc Biol 1997; 17: 940-6.
25 Pendurthi UR, Williams JT, Rao LVM. Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin: Suppression of activation of transcription factors Egr-1, AP-1 and NF-κB. Arterioscler Thromb Vasc Biol 1997; 17: 3406-17.
26 Oeth PA, Parry GCN, Kunsch C, Nanterment P, Rosen CA, Mackman N. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a κB-like site. Mol Cell Biol 1994; 14: 3772-81.
27 Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells require both activator protein 1 and nuclear factor κB binding sites. J Exp Med 1991; 174: 1517-26.
28 Schmitz ML, Baeuerle PA. The p65 subunit is responsible for the strong transcription activation potential of NF-κB. EMBO J 1991; 10: 3805-17.
29 Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNFinduced activation of nuclear transcription factors NF-κB, activator protein-1 and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 2000; 164: 6509-19.
30 Mackman N. Regulation of the tissue factor gene. Thromb Haemost 1997; 78: 747-54.
31 Oeth P, Parry GCN, Mackman N. Regulation of the tissue factor gene in human monocytic cells. Arterioscler Thromb Vasc Biol 1997; 17: 365-74.
32 Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995; 270: 16483-6.
33 Hunter T, Karin M. The regulation of transcription by phosphorylation. Cell 1992; 70: 375-87.
34 Egan LJ, Mays DC, Huntoon CJ, Bell MP, Pike MG, Sandborn WJ, Lipsky JJ, McKean DJ. Inhibition of interleukin-1-stimulated NF-κB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity. J Biol Chem 1999; 274: 26448-53.
35 Bierhaus A, Zhang Y, Quenhenberger P, Luther T, Haase M, Muller M, Mackman N, Ziegler R, Nawroth P. The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-κB. Thromb Haemost 1997; 77: 772-82.
36 Mackman N. Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers. J Biol Chem 1994; 269: 26363-7.
37 Oeth P, Mackman N. Salicylates inhibit lipopolysaccharide-induced transcriptional activation. Blood 1995; 86: 4144-52.
38 Wang D, Baldwin Jr AS. Activation of nuclear factor-κB-dependent transcription by tumor necrosis factor-a is mediated through phosphorylation of Rel A/p65 on serine 529. J Biol Chem 1998; 273: 29411-6.
39 Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1998; 01: 661-71.
40 Schmitz ML, dos Santos MASilva, Baeuerle PA. Transactivation domain 2 (TA2) of p65 NF-κB. J Biol Chem 1995; 270: 15576-84.
41 Tsai SH, Lin-Shiau S-Y, Lin JK. Suppression of nitrite oxide synthase and the down-regulation of the activation of NF-κB in macrophages by resveratrol. Br J Pharmacol 1999; 126: 673-80.
42 Holmes-McNary M, Baldwin Jr AS. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkB kinase. Cancer Res 2000; 60: 3477-83.
43 Wadsworth TL, Koop DR. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem Pharmacol 1999; 57: 941-9.
44 Bertelli AAE, Giovannini L, Stradi R, Urien S, Tillement J-P, Bertelli A. Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drugs Exptl Clin Res 1998; 24: 51-5.
45 Bertelli A, Bertelli AAE, Gozzini A, Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exptl Clin Res 1998; 24: 133-8.
46 Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, Goldberg DM. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 1996; 246: 163-82.
47 Seigneur M, Bonnet J, Dorian B. Effect of the consumption of alcohol, white wine, and red wine on platelet function and serum lipids. J Appli Cardiol 1990; 05: 215-22.
48 Whitehead TP, Robinson D, Allaway S, Syms J, Hale A. Effect of red wine ingestion on the antioxidant capacity of serum. Clin Chem 1995; 41: 32-5.
49 Wilson T, Knight TJ, Beitz DC, Lewis DS, Engen RL. Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits. Life Sciences 1996; 59: 15-21.
50 Brand K, Fowler BJ, Edgington TS, Mackman N. Tissue factor mRNA in THP-1 monocytic cell is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol 1991; 11: 4732-8.